ResMed Buy or Sell Recommendation

Macroaxis provides ResMed Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
ResMed Inc -- USA Stock  

USD 98.43  0.25  0.25%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed Inc is 'Buy'.
For the selected time horizon ResMed Inc has a risk adjusted performance of 0.2557, jensen alpha of 0.197, total risk alpha of 0.2178, sortino ratio of 0.2834 and treynor ratio of 1.05
Macroaxis provides advice on ResMed Inc to complement and cross-verify current analyst consensus on ResMed Inc. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed Inc fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed Inc has Price to Earning of 49.42 times, we recommend you check out ResMed Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.21Value At Risk1.04
Potential Upside1.75Standard Deviation0.88
 Return Density 

ResMed Greeks

Alpha over DOW
Beta against DOW=0.19
Overall volatility
Information ratio =0.25

ResMed Volatility Alert

ResMed Inc exhibits relatively low volatility with skewness of 0.26 and kurtosis of -0.18. However, we advice investors to further investigate ResMed Inc to make sure all market statistics is disseminated and is consistent with investors' estimations about ResMed upside potential.
 Better Than Average     
 Worse Than Average Compare ResMed to competition
FundamentalsResMedPeer Average
Return On Equity15.29 % (15.17) %
Return On Asset9.10 % (15.64) %
Profit Margin12.98 % (5.50) %
Operating Margin28.09 % (10.91) %
Current Valuation14.19 B152.14 B
Shares Outstanding142.93 M1.43 B
Shares Owned by Insiders1.14 % 6.91 %
Shares Owned by Institutions64.92 % 18.37 %
Price to Earning49.42 times40.69 times
Price to Book6.95 times14.44 times
Price to Sales6.39 times17.81 times
Revenue2.2 B9.85 B
Gross Profit1.2 B21.75 B
EBITDA616.88 M1.41 B
Net Income285.09 M517.71 M
Cash and Equivalents858.9 M3.89 B
Cash per Share6.01 times5.17 times
Total Debt1.02 B7.36 B
Debt to Equity50.40 % 0.72 %
Current Ratio1.29 times3.30 times
Book Value Per Share14.13 times13.64 times
Cash Flow from Operations174.38 M1.25 B
Earnings Per Share1.99 times2.30 times
Price to Earnings To Growth3.17 times1.22 times
Number of Employees6 K10.67 K
Market Capitalization14.03 B29.78 B
Total Asset3.26 B126.86 B
Retained Earnings2.16 B38.24 B
Working Capital781.73 M3.58 B
Current Asset1.42 B36.8 B
Current Liabilities637.99 M33.34 B
Z Score7.8708.73


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Exercise or conversion by Rob Douglas of 10000 shares of ResMed subject to Rule 16b-3 [view details]
Risk Adjusted Performance0.2557
Market Risk Adjusted Performance1.04
Mean Deviation0.7149
Semi Deviation0.5074
Downside Deviation0.7816
Coefficient Of Variation419.49
Standard Deviation0.8847
Information Ratio0.2504
Jensen Alpha0.197
Total Risk Alpha0.2178
Sortino Ratio0.2834
Treynor Ratio1.05
Maximum Drawdown3.12
Value At Risk1.04
Potential Upside1.75
Downside Variance0.611
Semi Variance0.2574
Expected Short fall0.86

Current Valuation

ResMed Current Valuation Analysis
ResMed Inc is rated fourth in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Medical Equipment industry is at this time estimated at about 123.56 Billion. ResMed retains roughly 14.19 Billion in current valuation claiming about 11% of all equities under Medical Equipment industry.